• brain tumor patient Allison

    Amazing Allison: A Young 'Pioneer' and the Boston Doctors Who Saved Her

    WBZ-TV anchor Lisa Hughes reports on a young brain tumor patient who became the first child on a targeted therapy trial for an adult skin cancer.
    precision medicine graphic

    iCat Study Finds Genetic Sequencing Can Help Guide Treatment in Children with Solid Tumors

    Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors, according to one of the first pediatric studies of its kind.
    Sophie after brain tumor surgery

    Holiday Concert One Year After Brain Tumor Surgery

    A holiday concert brings together a girl and the surgeon who removed her brain tumor.
    sickle cell blood cell

    Gene Editing Study Reveals Possible "Achilles Heel" of Sickle Cell Disease

    Dana-Farber/Boston Children's researchers found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease.
    Car t-cell image

    Immunotherapy Clinical Trial for Relapsed Leukemia

    Dana-Farber/Boston Children's is the first and only site in New England to offer a breakthrough immunotherapy clinical trial for children with relapsed or treatment-resistant acute lymphoblastic leukemia.
  • Ranked #1 for Cancer Care

    US News

    Rated the top pediatric
    cancer center by U.S. News & World Report

  • Why Choose Us?

    Not only are we a top cancer and blood disease center, we're also a top pediatric hospital. Above, our physicians explain how our vast clinical resources benefit patients.

  • Follow Us!

    Twitter Logo Follow us on Twitter.